Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-20-002690
Filing Date
2020-02-26
Accepted
2020-02-26 21:00:57
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 31552
2 GRAPHIC g855212g97q57.jpg GRAPHIC 3305
  Complete submission text file 0000950123-20-002690.txt   37223
Mailing Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE, SUITE 120 (BLD E) LEDGEMONT TECHNOLOGY CENTER LEXINGTON MA 02421 617-513-8774
Keros Therapeutics, Inc. (Filer) CIK: 0001664710 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations